2025 Q4 -tulosraportti
Vain PDF
21 päivää sitten
Tarjoustasot
Spotlight Stock Market DK
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 53 | SSWM | SWB | ||
| 70 | NON | SWB | ||
| 85 | AVA | SWB | ||
| 13 | NON | SWB | ||
| 30 | NRD | SWB |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Avanza Bank AB | 5 973 | 1 459 | +4 514 | 923 |
| Svenska Handelsbanken AB | 500 | 0 | +500 | 0 |
| Nordea Bank Abp | 306 | 0 | +306 | 0 |
| SSW Market Making GmbH | 168 | 168 | 0 | 0 |
| Swedbank AB | 0 | 251 | −251 | 0 |
| Skandinaviska Enskilda Banken AB | 0 | 2 301 | −2 301 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 9 098 | 11 866 | −2 768 | 7 248 |
| Skandinaviska Enskilda Banken AB | 0 | 2 301 | −2 301 | 0 |
| Swedbank AB | 0 | 251 | −251 | 0 |
| SSW Market Making GmbH | 168 | 168 | 0 | 0 |
| Nordea Bank Abp | 306 | 0 | +306 | 0 |
| Svenska Handelsbanken AB | 500 | 0 | +500 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 28.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 13.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 15.5.2025 | ||
2024 Q4 -tulosraportti 28.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·1 päivä sittenI have prepared myself for a launch in the US earliest May/June this year. I imagine that STAQ pharma (who might actually be them - as the distributor of the product in the USA) who determines the launch time) wants to see 6 months stability results for drug product batches manufactured in the USA. This makes it possible to bridge to the already available stability trials that have been performed for batches produced by the European manufacturer. Thus, STAQ can "borrow" the shelf life that can be established for the European batches for the American-manufactured batches. I think that the stability batches in the USA were initiated in connection with tech transfer in Oct 2025. Six months storage of stability batches + 1 month to analyze the final samples brings us to May, if everything goes as planned. I don't think that Cessatech/Ventis dares to state a launch date before they know US stability data and know that they support a commercially reasonable shelf life for the product. And they probably won't know that until May. I don't think they want to promise a launch in May/June with the risk of discovering at that time that US stability data unexpectedly doesn't hold up, so they are forced to either abandon a launch or wait for an additional 3 - 6 months of data. They have previously been bold in their statements about a launch and got burned by it. They don't want to play that game again. So I expect radio silence (perhaps apart from everything going according to plan in US and EU) for a couple of months. This comes after an expectation that there might be information about launch plans in connection with the Denver conference last. But as hinted above, there was probably a reason why it didn't happen.·10 t sittenIt's odd that Jes recently came out and said that it wouldn't be many weeks before launch – though he said that at the end of February.·6 t sittenRight. I had missed that. At some point, one should probably go from calculating in weeks to months.
·2 päivää sittenI can't help but think... is this the new “Zealand Pharma” that people day trade on no news. I truly hope that at the congress some good prospects for the future for cessatech are given so people can stay and the stock becomes stable.
·2 päivää sittenDon't know how easy it is to day trade with 58.xxx kr in turnover- ·3 päivää sittenYes, right until someone pushes it down again. Damn it, man. There are some who don't want it to rise.
3 päivää sitten3 päivää sittenTämä julkaisu on poistettu.
·3 päivää sittenOnly 25 shares sold at that price, so probably a form of manipulation
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
21 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenI have prepared myself for a launch in the US earliest May/June this year. I imagine that STAQ pharma (who might actually be them - as the distributor of the product in the USA) who determines the launch time) wants to see 6 months stability results for drug product batches manufactured in the USA. This makes it possible to bridge to the already available stability trials that have been performed for batches produced by the European manufacturer. Thus, STAQ can "borrow" the shelf life that can be established for the European batches for the American-manufactured batches. I think that the stability batches in the USA were initiated in connection with tech transfer in Oct 2025. Six months storage of stability batches + 1 month to analyze the final samples brings us to May, if everything goes as planned. I don't think that Cessatech/Ventis dares to state a launch date before they know US stability data and know that they support a commercially reasonable shelf life for the product. And they probably won't know that until May. I don't think they want to promise a launch in May/June with the risk of discovering at that time that US stability data unexpectedly doesn't hold up, so they are forced to either abandon a launch or wait for an additional 3 - 6 months of data. They have previously been bold in their statements about a launch and got burned by it. They don't want to play that game again. So I expect radio silence (perhaps apart from everything going according to plan in US and EU) for a couple of months. This comes after an expectation that there might be information about launch plans in connection with the Denver conference last. But as hinted above, there was probably a reason why it didn't happen.·10 t sittenIt's odd that Jes recently came out and said that it wouldn't be many weeks before launch – though he said that at the end of February.·6 t sittenRight. I had missed that. At some point, one should probably go from calculating in weeks to months.
- ·2 päivää sittenI can't help but think... is this the new “Zealand Pharma” that people day trade on no news. I truly hope that at the congress some good prospects for the future for cessatech are given so people can stay and the stock becomes stable.·2 päivää sittenDon't know how easy it is to day trade with 58.xxx kr in turnover
- ·3 päivää sittenYes, right until someone pushes it down again. Damn it, man. There are some who don't want it to rise.
- 3 päivää sitten3 päivää sittenTämä julkaisu on poistettu.·3 päivää sittenOnly 25 shares sold at that price, so probably a form of manipulation
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Spotlight Stock Market DK
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 53 | SSWM | SWB | ||
| 70 | NON | SWB | ||
| 85 | AVA | SWB | ||
| 13 | NON | SWB | ||
| 30 | NRD | SWB |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Avanza Bank AB | 5 973 | 1 459 | +4 514 | 923 |
| Svenska Handelsbanken AB | 500 | 0 | +500 | 0 |
| Nordea Bank Abp | 306 | 0 | +306 | 0 |
| SSW Market Making GmbH | 168 | 168 | 0 | 0 |
| Swedbank AB | 0 | 251 | −251 | 0 |
| Skandinaviska Enskilda Banken AB | 0 | 2 301 | −2 301 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 9 098 | 11 866 | −2 768 | 7 248 |
| Skandinaviska Enskilda Banken AB | 0 | 2 301 | −2 301 | 0 |
| Swedbank AB | 0 | 251 | −251 | 0 |
| SSW Market Making GmbH | 168 | 168 | 0 | 0 |
| Nordea Bank Abp | 306 | 0 | +306 | 0 |
| Svenska Handelsbanken AB | 500 | 0 | +500 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 28.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 13.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 15.5.2025 | ||
2024 Q4 -tulosraportti 28.2.2025 |
2025 Q4 -tulosraportti
Vain PDF
21 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 28.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 13.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 15.5.2025 | ||
2024 Q4 -tulosraportti 28.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenI have prepared myself for a launch in the US earliest May/June this year. I imagine that STAQ pharma (who might actually be them - as the distributor of the product in the USA) who determines the launch time) wants to see 6 months stability results for drug product batches manufactured in the USA. This makes it possible to bridge to the already available stability trials that have been performed for batches produced by the European manufacturer. Thus, STAQ can "borrow" the shelf life that can be established for the European batches for the American-manufactured batches. I think that the stability batches in the USA were initiated in connection with tech transfer in Oct 2025. Six months storage of stability batches + 1 month to analyze the final samples brings us to May, if everything goes as planned. I don't think that Cessatech/Ventis dares to state a launch date before they know US stability data and know that they support a commercially reasonable shelf life for the product. And they probably won't know that until May. I don't think they want to promise a launch in May/June with the risk of discovering at that time that US stability data unexpectedly doesn't hold up, so they are forced to either abandon a launch or wait for an additional 3 - 6 months of data. They have previously been bold in their statements about a launch and got burned by it. They don't want to play that game again. So I expect radio silence (perhaps apart from everything going according to plan in US and EU) for a couple of months. This comes after an expectation that there might be information about launch plans in connection with the Denver conference last. But as hinted above, there was probably a reason why it didn't happen.·10 t sittenIt's odd that Jes recently came out and said that it wouldn't be many weeks before launch – though he said that at the end of February.·6 t sittenRight. I had missed that. At some point, one should probably go from calculating in weeks to months.
- ·2 päivää sittenI can't help but think... is this the new “Zealand Pharma” that people day trade on no news. I truly hope that at the congress some good prospects for the future for cessatech are given so people can stay and the stock becomes stable.·2 päivää sittenDon't know how easy it is to day trade with 58.xxx kr in turnover
- ·3 päivää sittenYes, right until someone pushes it down again. Damn it, man. There are some who don't want it to rise.
- 3 päivää sitten3 päivää sittenTämä julkaisu on poistettu.·3 päivää sittenOnly 25 shares sold at that price, so probably a form of manipulation
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Spotlight Stock Market DK
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 53 | SSWM | SWB | ||
| 70 | NON | SWB | ||
| 85 | AVA | SWB | ||
| 13 | NON | SWB | ||
| 30 | NRD | SWB |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Avanza Bank AB | 5 973 | 1 459 | +4 514 | 923 |
| Svenska Handelsbanken AB | 500 | 0 | +500 | 0 |
| Nordea Bank Abp | 306 | 0 | +306 | 0 |
| SSW Market Making GmbH | 168 | 168 | 0 | 0 |
| Swedbank AB | 0 | 251 | −251 | 0 |
| Skandinaviska Enskilda Banken AB | 0 | 2 301 | −2 301 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 9 098 | 11 866 | −2 768 | 7 248 |
| Skandinaviska Enskilda Banken AB | 0 | 2 301 | −2 301 | 0 |
| Swedbank AB | 0 | 251 | −251 | 0 |
| SSW Market Making GmbH | 168 | 168 | 0 | 0 |
| Nordea Bank Abp | 306 | 0 | +306 | 0 |
| Svenska Handelsbanken AB | 500 | 0 | +500 | 0 |